Gangolli Julian S

CVP & Pres, North America at ALLERGAN INC · on record since Nov 30, 2011
Director at Revance Therapeutics, Inc. · on record since Jul 6, 2016
President, North America at GW PHARMACEUTICALS PLC · on record since Oct 1, 2018
Director at Krystal Biotech, Inc. · on record since Mar 6, 2019
Director at Outlook Therapeutics, Inc. · on record since Apr 21, 2020

Insider trading activity of Gangolli Julian S

Transactions on record: 121; since Nov 30, 2011

Open-market buys: 0

Open-market sells: 17; $27.4M

Companies traded: 5; last filing Oct 3, 2025

Figures computed from official regulatory filings — methodology.

Companies where Gangolli Julian S has traded

Outlook Therapeutics, Inc.14 tx · $111.5K · Oct 3, 2025
Krystal Biotech, Inc.12 tx · $3.7M · Jun 30, 2025
Revance Therapeutics, Inc.20 tx · $109.9K · Feb 6, 2025
GW PHARMACEUTICALS PLC21 tx · $11.6M · May 14, 2019
ALLERGAN INC54 tx · $27.6M · Mar 19, 2015

Track record of Gangolli Julian S

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Gangolli Julian S

Co-insiders of Gangolli Julian S

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
Outlook Therapeutics, Inc.	Oct 3, 2025	AwardD	286,734	0.00 USD	$0	SEC
Krystal Biotech, Inc.	Jun 30, 2025	AwardD	5,000	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	Feb 6, 2025	Other	-30,106	3.65 USD	$109.9K	SEC
Revance Therapeutics, Inc.	Feb 6, 2025	Other	-15,000	—	—	SEC
Outlook Therapeutics, Inc.	Oct 3, 2024	AwardD	71,169	0.00 USD	$0	SEC
Outlook Therapeutics, Inc.	Oct 3, 2024	AwardD	56,636	0.00 USD	$0	SEC
Krystal Biotech, Inc.	Jul 1, 2024	AwardD	5,000	0.00 USD	$0	SEC
Krystal Biotech, Inc.	May 22, 2024	Exercise	20,000	22.75 USD	$455K	SEC
Krystal Biotech, Inc.	May 22, 2024	Sell	-7,090	164.34 USD	$1.2M	SEC
Krystal Biotech, Inc.	May 22, 2024	Sell	-10,930	163.71 USD	$1.8M	SEC
Krystal Biotech, Inc.	May 22, 2024	Sell	-1,980	165.76 USD	$328.2K	SEC
Krystal Biotech, Inc.	May 22, 2024	ExerciseD	-20,000	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 3, 2024	Award	15,000	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 3, 2024	AwardD	23,458	0.00 USD	$0	SEC
Outlook Therapeutics, Inc.	Mar 8, 2024	AwardD	94,441	0.00 USD	$0	SEC
Outlook Therapeutics, Inc.	Oct 6, 2023	AwardD	370,282	0.00 USD	$0	SEC
Krystal Biotech, Inc.	Jul 3, 2023	AwardD	6,800	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 5, 2023	Award	3,534	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 5, 2023	AwardD	5,915	0.00 USD	$0	SEC
Outlook Therapeutics, Inc.	Mar 31, 2023	AwardD	41,065	0.00 USD	$0	SEC
Outlook Therapeutics, Inc.	Oct 7, 2022	AwardD	74,398	0.00 USD	$0	SEC
Krystal Biotech, Inc.	Jul 1, 2022	AwardD	6,800	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 13, 2022	AwardD	10,756	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 6, 2022	Award	6,059	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 6, 2022	AwardD	11,343	0.00 USD	$0	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Outlook Therapeutics, Inc.	Oct 3, 2025	AwardD	286,734	0.00 USD	$0	SEC
Krystal Biotech, Inc.	Jun 30, 2025	AwardD	5,000	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	Feb 6, 2025	Other	-30,106	3.65 USD	$109.9K	SEC
Revance Therapeutics, Inc.	Feb 6, 2025	Other	-15,000	—	—	SEC
Outlook Therapeutics, Inc.	Oct 3, 2024	AwardD	71,169	0.00 USD	$0	SEC
Outlook Therapeutics, Inc.	Oct 3, 2024	AwardD	56,636	0.00 USD	$0	SEC
Krystal Biotech, Inc.	Jul 1, 2024	AwardD	5,000	0.00 USD	$0	SEC
Krystal Biotech, Inc.	May 22, 2024	Exercise	20,000	22.75 USD	$455K	SEC
Krystal Biotech, Inc.	May 22, 2024	Sell	-7,090	164.34 USD	$1.2M	SEC
Krystal Biotech, Inc.	May 22, 2024	Sell	-10,930	163.71 USD	$1.8M	SEC
Krystal Biotech, Inc.	May 22, 2024	Sell	-1,980	165.76 USD	$328.2K	SEC
Krystal Biotech, Inc.	May 22, 2024	ExerciseD	-20,000	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 3, 2024	Award	15,000	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 3, 2024	AwardD	23,458	0.00 USD	$0	SEC
Outlook Therapeutics, Inc.	Mar 8, 2024	AwardD	94,441	0.00 USD	$0	SEC
Outlook Therapeutics, Inc.	Oct 6, 2023	AwardD	370,282	0.00 USD	$0	SEC
Krystal Biotech, Inc.	Jul 3, 2023	AwardD	6,800	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 5, 2023	Award	3,534	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 5, 2023	AwardD	5,915	0.00 USD	$0	SEC
Outlook Therapeutics, Inc.	Mar 31, 2023	AwardD	41,065	0.00 USD	$0	SEC
Outlook Therapeutics, Inc.	Oct 7, 2022	AwardD	74,398	0.00 USD	$0	SEC
Krystal Biotech, Inc.	Jul 1, 2022	AwardD	6,800	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 13, 2022	AwardD	10,756	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 6, 2022	Award	6,059	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 6, 2022	AwardD	11,343	0.00 USD	$0	SEC